• Home (current)
  • Products
    Electronic Materials
    Biomedical Materials
    Energy Materials
    Screening Compounds
    Biochemicals
    Chemical Synthesis
    Catalysts
    Chemical Biology
    Flavors & Fragrances
    Amino Acids Resins & Reagents
    Building Blocks
    Lab Chemicals
    Stable Isotopes
    Formulation
    Portfolio APIs
    Bioactive Small Molecules
    Reference Materials
    Analytical Reagents
    Analytical Chromatography
    Pathways
  • Services
    Custom Synthesis Solutions Impurity Profiling and Characterization Peptide Synthesis Services Structural Analysis Services Chiral Compound Synthesis Fluorescent Labeling and Probes Bioconjugation and Linker Chemistry High-Throughput Screening and Assays
  • Articles
    Pharmaceutical R&D Cardiovascular Diseases Respiratory Diseases Cancer Viral Infections Mental Disorders Senescence and Aging Neurodegenerative Diseases Bacterial Infections
  • About Us
    About Us Contact Us Instructions Privacy Policies Intellectual Property Promise Terms
Home / Articles
May
27
Small Molecule Compounds and the STAT3 Signaling Pathway
stat3-pathway
Small Molecule Compounds and the STAT3 Signaling Pathway
Signal transducer and activator of transcription 3 (STAT3) is a member of a family of seven proteins (STAT-1, −2, −3, −4, −5A, −5B and −6) that relay signals from activated cytokine and growth factor receptors in the plasma membrane to the nucleus, where they regulate gene transcription. In healthy cells, the activation of STATs is tightly regulated to prevent uncontrolled gene expression; however, prolonged activation of STATs in cancer cells may result in significant adverse effects, such as drug resistance and poor prognosis.
May
12
Small Molecule Compounds and the Hedgehog Signaling Pathway
hedgehog-pathway
Small Molecule Compounds and the Hedgehog Signaling Pathway
The hedgehog signaling pathway is a mechanism that directs the development of embryonic cells in animals, from invertebrates to vertebrates. The hedgehog signaling pathway was first discovered in Drosophila by Wieschaus and Nüsslein‐Vollhard in the early 1980s. The pathway takes its name from its polypeptide ligand, an intracellular signaling molecule called Hedgehog (Hh) found in fruit flies of the genus Drosophila; fruit fly larva lacking the Hh gene are said to resemble hedgehogs. Hh is one of Drosophila's segment polarity gene products, involved in establishing the basis of the fly body plan.
May
01
Small Molecule Compounds and the PI3K Signaling Pathway
pi3k-pathway
Small Molecule Compounds and the PI3K Signaling Pathway
First discovered by Lewis Cantley and colleagues, the phosphoinositide 3-kinase (PI3K) signaling is one of the pathways controlling cell survival, proliferation, and apoptosis. PI3Ks are a large family of lipid enzymes that phosphorylate the 3’-OH group of phosphatidylinositols (PI) at the plasma membrane.
Apr
24
Small Molecule Compounds and the Nrf2 Signaling Pathway
nrf2-pathway
Small Molecule Compounds and the Nrf2 Signaling Pathway
Nrf2 (NF-E2-related factor 2), a member of the Cap’n’collar (CNC) transcription factor family, consists of 605 amino acids and is divided into seven highly conserved functional domains, known as Neh1-Neh7. The N-terminal domain influences the stability and ubiquitination of Nrf2 by its negative regulator Keap1, while the Neh5 domain is responsible for the cytoplasmic localization of Nrf2.
Apr
02
Neurodegenerative Diseases: Etiology, Research, and Recent Advances in Treatment
protease-beta-secretase
Neurodegenerative Diseases: Etiology, Research, and Recent Advances in Treatment
Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don‘t reproduce or replace themselves, so when they become damaged or die, they cannot be replaced by the body. A neurodegenerative disease is caused by the progressive loss of structure or function of neurons, in the process known as neurodegeneration. Such neuronal damage may ultimately involve cell death. Neurodegenerative disease is an umbrella term for a range of these conditions.
Mar
22
Potential Treatment for Multiple Myeloma - CDK6 upregulation as a druggable target (March 2022)
cdk6-inhibitors-antagonists
Potential Treatment for Multiple Myeloma - CDK6 upregulation as a druggable target (March 2022)
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In multiple myeloma, the overgrowth of plasma cells in the bone marrow can crowd out normal blood-forming cells, leading to low blood counts. Myeloma cells also interfere with cells that help keep bones strong.
2 3 4 5 6
Category
Pharmaceutical R&D
Cardiovascular Diseases
Respiratory Diseases
Cancer
Viral Infections
Mental Disorders
Senescence and Aging
Neurodegenerative Diseases
Bacterial Infections
Latest Posts
Machine learning optimized antibodies yield highly diverse and affinity-rich antibody libraries
11 23 2023
Differentiating and Predicting Drug Patents
10 11 2023
Antibiotic discovery targeting Acinetobacter baumannii guided by deep learning
09 25 2023
Molecular information transfer network and chirality
09 21 2023
A Multimodal Protein Representation Framework for Quantifying Downstream Biochemical Tasks
09 18 2023
Small Molecule Compounds and the MAPK/ERK Signaling Pathway
05 16 2023
Popular Tags
hPSCs DDR Cellular Senescence Himastatin VEGF Pathway NF-κB Pathway
Your Ultimate Destination for Small-Molecule (aka. smolecule) Compounds, Empowering Innovative Research Solutions Beyond Boundaries.
Contact US
Customer Support Hotline
(512) 262-9938
Inquiries and Technical Support:
info@smolecule.com
Products
Materials Science
Chemistry & Biochemicals
Pharma & Biopharma Manufacturing
Protein Biology
Analytical Chemistry
Inhibitors
Services
Custom Synthesis Solutions
Impurity Profiling and Characterization
Peptide Synthesis Services
Structural Analysis Services
Chiral Compound Synthesis
Fluorescent Labeling and Probes
Bioconjugation and Linker Chemistry
High-Throughput Screening and Assays
Articles
Pharmaceutical R&D
Cardiovascular Diseases
Respiratory Diseases
Cancer
Viral Infections
Mental Disorders
Senescence and Aging
Neurodegenerative Diseases
Bacterial Infections
© 2024 Smolecule Inc. All rights reserved.
Privacy Policies · Intellectual Property Promise · Terms